Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Naito, T; Okada, T; Ogasawara, H; Kaneko, H; Hishikawa, T; Matsumoto, T; Sekigawa, I; Hashimoto, H; Kaneko, Y
   Curdlan sulfate induces the downmodulation of chemokine receptors leading to suppression of HIV infection
   JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
   
   T. Naito et al., "Curdlan sulfate induces the downmodulation of chemokine receptors leading to suppression of HIV infection", J ACQ IMM D, 26(5), 2001, pp. 512-513
2. Ogasawara, H; Okada, M; Kaneko, H; Hishikawa, T; Sekigawa, I; Iida, N; Maruyama, N; Yamamoto, N; Hashimoto, H
   Quantitative comparison of human endogenous retrovirus mRNA between SLE and rheumatoid arthritis
   LUPUS
   
   H. Ogasawara et al., "Quantitative comparison of human endogenous retrovirus mRNA between SLE and rheumatoid arthritis", LUPUS, 10(7), 2001, pp. 517-518
3. Sekigawa, I; Ogasawara, H; Kaneko, H; Hishikawa, T; Hashimoto, H
   Retroviruses and autoimmunity
   INTERNAL MEDICINE
   
   I. Sekigawa et al., "Retroviruses and autoimmunity", INTERN MED, 40(2), 2001, pp. 80-86
4. Ogasawara, H; Hishikawa, T; Sekigawa, I; Hashimoto, H; Yamamoto, N; Maruyama, N
   Sequence analysis of human endogenous retrovirus clone 4-1 in systemic lupus erythematosus
   AUTOIMMUNITY
   
   H. Ogasawara et al., "Sequence analysis of human endogenous retrovirus clone 4-1 in systemic lupus erythematosus", AUTOIMMUN, 33(1), 2001, pp. 15-21
5. Ogasawara, H; Naito, T; Kaneko, H; Hishikawa, T; Sekigawa, I; Hashimoto, H; Kaneko, Y; Yamamoto, N; Maruyama, N; Yamamoto, N
   Quantitative analyses of messenger RNA of human endogenous retrovirus in patients with systemic lupus erythematosus
   JOURNAL OF RHEUMATOLOGY
   
   H. Ogasawara et al., "Quantitative analyses of messenger RNA of human endogenous retrovirus in patients with systemic lupus erythematosus", J RHEUMATOL, 28(3), 2001, pp. 533-538
6. Kikuchi, T; Matsuguchi, T; Tsuboi, N; Mitani, A; Tanaka, S; Matsuoka, M; Yamamoto, G; Hishikawa, T; Noguchi, T; Yoshikai, Y
   Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via toll-like receptors
   JOURNAL OF IMMUNOLOGY
   
   T. Kikuchi et al., "Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via toll-like receptors", J IMMUNOL, 166(5), 2001, pp. 3574-3579
7. Ogasawara, K; Kaneko, H; Hishikawa, T; Sekigawa, I; Takasaki, Y; Hashimoto, H; Hirose, S; Kaneko, Y; Maruyama, N
   Molecular mimicry between human endogenous retrovirus clone 4-1 and HLA class I antigen with reference to the pathogenesis of systemic lupus erythematosus
   RHEUMATOLOGY
   
   K. Ogasawara et al., "Molecular mimicry between human endogenous retrovirus clone 4-1 and HLA class I antigen with reference to the pathogenesis of systemic lupus erythematosus", RHEUMATOLOG, 38(11), 1999, pp. 1163-1164
8. Ichiyama, K; Akimoto, H; Neoh, LP; Takeda-Hirokawa, N; Kaneko, H; Hishikawa, T; Hashimoto, H; Hirose, S; Kaneko, Y; Yamamoto, N; Sekigawa, I
   HIV type 2 can bind to CD8 molecules but does not infect CD8(+) T cells
   AIDS RESEARCH AND HUMAN RETROVIRUSES
   
   K. Ichiyama et al., "HIV type 2 can bind to CD8 molecules but does not infect CD8(+) T cells", AIDS RES H, 15(7), 1999, pp. 687-688
9. Kaneko, H; Ogasawara, H; Naito, T; Akimoto, H; Lee, S; Hishikawa, T; Sekigawa, I; Tokano, Y; Takasaki, Y; Hirose, SI; Hashimoto, H
   Circulating levels of beta-chemokines in systemic lupus erythematosus
   JOURNAL OF RHEUMATOLOGY
   
   H. Kaneko et al., "Circulating levels of beta-chemokines in systemic lupus erythematosus", J RHEUMATOL, 26(3), 1999, pp. 568-573
10. SUGIYAMA M; OGASAWARA H; KANEKO H; HISHIKAWA T; SEKIGAWA I; IIDA N; HASHIMOTO H; HIROSE S
    EFFECT OF EXTREMELY LOW-DOSE CYCLOSPORINE TREATMENT ON THE THROMBOCYTOPENIA IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    Lupus
    
    M. Sugiyama et al., "EFFECT OF EXTREMELY LOW-DOSE CYCLOSPORINE TREATMENT ON THE THROMBOCYTOPENIA IN SYSTEMIC LUPUS-ERYTHEMATOSUS", Lupus, 7(1), 1998, pp. 53-56
11. TAKEDAHIROKAWA N; NEOH LP; AKIMOTO H; KANEKO H; HISHIKAWA T; HASHIMOTO H; SEKIGAWA I; HIROSE SI; YAMANOTO N; KANEKO Y
    EFFECT OF CURDLAN SULFATE ON THE PRODUCTION OF BETA-CHEMOKINES AND CYTOKINES
    AIDS research and human retroviruses
    
    N. Takedahirokawa et al., "EFFECT OF CURDLAN SULFATE ON THE PRODUCTION OF BETA-CHEMOKINES AND CYTOKINES", AIDS research and human retroviruses, 14(9), 1998, pp. 723-725
12. SEKIGAWA I; KANEKO H; NEOH LP; TAKEDAHIROKAWA N; AKIMOTO H; HISHIKAWA T; HASHIMOTO H; HIROSE S; YAMAMOTO N; KANEKO Y
    DIFFERENCES OF HIV ENVELOPE PROTEIN BETWEEN HIV-1 AND HIV-2 - POSSIBLE RELATION TO THE LOWER VIRULENCE OF HIV-2
    Viral immunology
    
    I. Sekigawa et al., "DIFFERENCES OF HIV ENVELOPE PROTEIN BETWEEN HIV-1 AND HIV-2 - POSSIBLE RELATION TO THE LOWER VIRULENCE OF HIV-2", Viral immunology, 11(1), 1998, pp. 1-8
13. OGASAWARA H; SEKIYA M; MURASHIMA A; HISHIKAWA T; TOKANO Y; SEKIGAWA I; IIDA N; HASHIMOTO H; HIROSE S
    VERY LOW-DOSE CYCLOSPORINE TREATMENT OF STEROID-RESISTANT INTERSTITIAL PNEUMONITIS ASSOCIATED WITH SJOGRENS-SYNDROME
    Clinical rheumatology
    
    H. Ogasawara et al., "VERY LOW-DOSE CYCLOSPORINE TREATMENT OF STEROID-RESISTANT INTERSTITIAL PNEUMONITIS ASSOCIATED WITH SJOGRENS-SYNDROME", Clinical rheumatology, 17(2), 1998, pp. 160-162
14. SEKIGAWA I; OGASAWARA H; SUGIYAMA M; KANEKO H; HISHIKAWA T; TOKANO Y; IIDA N; HAHIMOTO H; HIROSE S
    EXTREMELY LOW-DOSE TREATMENT OF CYCLOSPORINE FOR AUTOIMMUNE-DISEASES
    Clinical and experimental rheumatology
    
    I. Sekigawa et al., "EXTREMELY LOW-DOSE TREATMENT OF CYCLOSPORINE FOR AUTOIMMUNE-DISEASES", Clinical and experimental rheumatology, 16(3), 1998, pp. 352-352
15. SEKIGAWA I; KANEKO H; HISHIKAWA T; HASHIMOTO H; HIROSE S; KANEKO Y; MARUYAMA N
    HIV-INFECTION AND SLE - THEIR PATHOGENIC RELATIONSHIP
    Clinical and experimental rheumatology
    
    I. Sekigawa et al., "HIV-INFECTION AND SLE - THEIR PATHOGENIC RELATIONSHIP", Clinical and experimental rheumatology, 16(2), 1998, pp. 175-180
16. OGASAWARA H; MURASHIMA A; KANEKO H; HISHIKAWA T; TOKANO Y; SEKIGAWA I; IIDA N; HASHIMOTO H; HIROSE S
    EFFECT OF LOW-DOSE CYCLOSPORINE TREATMENT ON INTERSTITIAL PNEUMONITISASSOCIATED WITH SJOGRENS-SYNDROME
    British journal of rheumatology
    
    H. Ogasawara et al., "EFFECT OF LOW-DOSE CYCLOSPORINE TREATMENT ON INTERSTITIAL PNEUMONITISASSOCIATED WITH SJOGRENS-SYNDROME", British journal of rheumatology, 37(3), 1998, pp. 348-349
17. MORI T; MATSUMURA M; KANAMARU Y; MIYANO S; HISHIKAWA T; IRIE S; OSHIMI K; SAIKAWA T; OGURI T
    MYELOFIBROSIS COMPLICATED BY INFECTION DUE TO CANDIDA-ALBICANS - EMERGENCE OF RESISTANCE TO ANTIFUNGAL AGENTS DURING THERAPY
    Clinical infectious diseases
    
    T. Mori et al., "MYELOFIBROSIS COMPLICATED BY INFECTION DUE TO CANDIDA-ALBICANS - EMERGENCE OF RESISTANCE TO ANTIFUNGAL AGENTS DURING THERAPY", Clinical infectious diseases, 25(6), 1997, pp. 1470-1471
18. KUBOTA S; HISHIKAWA T; MAKINO M; USHIDA K; MOMOSE T; SHIDA T
    NOVEL INTRAMOLECULAR HYDROGEN ABSTRACTION IN THE RADICAL-CATION OF SOME DIOXACYCLOHEXANES AS STUDIED BY EPR SPECTROSCOPY AND KINETIC-ANALYSIS
    Acta chemica Scandinavica
    
    S. Kubota et al., "NOVEL INTRAMOLECULAR HYDROGEN ABSTRACTION IN THE RADICAL-CATION OF SOME DIOXACYCLOHEXANES AS STUDIED BY EPR SPECTROSCOPY AND KINETIC-ANALYSIS", Acta chemica Scandinavica, 51(5), 1997, pp. 579-584
19. HISHIKAWA T; OGASAWARA H; KANEKO H; SHIRASAWA T; MATSUURA Y; SEKIGAWA I; TAKASAKI Y; HASHIMOTO H; HIROSE S; HANDA S; NAGASAWA R; MARUYAMA N
    DETECTION OF ANTIBODIES TO A RECOMBINANT GAG PROTEIN-DERIVED FROM HUMAN ENDOGENOUS RETROVIRUS CLONE-4-1 IN AUTOIMMUNE-DISEASES
    Viral immunology
    
    T. Hishikawa et al., "DETECTION OF ANTIBODIES TO A RECOMBINANT GAG PROTEIN-DERIVED FROM HUMAN ENDOGENOUS RETROVIRUS CLONE-4-1 IN AUTOIMMUNE-DISEASES", Viral immunology, 10(3), 1997, pp. 137-147
20. TAKEDAHIROKAWA N; NEOH LP; AKIMOTO H; KANEKO H; HISHIKAWA T; SEKIGAWA I; HASHIMOTO H; HIROSE S; MURAKAMI T; YAMAMOTO N; MIMURA T; KANEKO Y
    ROLE OF CURDLAN SULFATE IN THE BINDING OF HIV-1 GP120 TO CD4 MOLECULES AND THE PRODUCTION OF GP120-MEDIATED TNF-ALPHA
    Microbiology and immunology
    
    N. Takedahirokawa et al., "ROLE OF CURDLAN SULFATE IN THE BINDING OF HIV-1 GP120 TO CD4 MOLECULES AND THE PRODUCTION OF GP120-MEDIATED TNF-ALPHA", Microbiology and immunology, 41(9), 1997, pp. 741-745
21. SEKIYA M; SEKIGAWA I; HISHIKAWA T; IIDA N; HASHIMOTO H; HIROSE S
    NODULAR REGENERATIVE HYPERPLASIA OF THE LIVER IN SYSTEMIC LUPUS-ERYTHEMATOSUS - THE RELATIONSHIP WITH ANTICARDIOLIPIN ANTIBODY AND LUPUS ANTICOAGULANT
    Scandinavian journal of rheumatology
    
    M. Sekiya et al., "NODULAR REGENERATIVE HYPERPLASIA OF THE LIVER IN SYSTEMIC LUPUS-ERYTHEMATOSUS - THE RELATIONSHIP WITH ANTICARDIOLIPIN ANTIBODY AND LUPUS ANTICOAGULANT", Scandinavian journal of rheumatology, 26(3), 1997, pp. 215-217
22. TOKANO Y; MORIMOTO S; HISHIKAWA T; MURASHIMA A; ABE M; SEKIGAWA I; TAKASAKI Y; HASHIMOTO H; OKUMURA K; SHIRAI T; HIROSE S
    SUBSETS OF ACTIVATED T-CELLS IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - THE RELATION TO CELL-CYCLE
    Scandinavian journal of rheumatology
    
    Y. Tokano et al., "SUBSETS OF ACTIVATED T-CELLS IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - THE RELATION TO CELL-CYCLE", Scandinavian journal of rheumatology, 26(1), 1997, pp. 37-42
23. LEE S; SUGIYAMA M; HISHIKAWA T; SEKIGAWA I; IIDA N; HASHIMOTO H; HIROSE S
    THROMBOCYTOPENIA IN SYSTEMIC LUPUS-ERYTHEMATOSUS ASSOCIATED WITH CYTOMEGALOVIRUS-INFECTION
    Scandinavian journal of rheumatology
    
    S. Lee et al., "THROMBOCYTOPENIA IN SYSTEMIC LUPUS-ERYTHEMATOSUS ASSOCIATED WITH CYTOMEGALOVIRUS-INFECTION", Scandinavian journal of rheumatology, 26(1), 1997, pp. 69-69
24. NEOH LP; AKIMOTO H; KANEKO H; HISHIKAWA T; HASHIMOTO H; HIROSE S; KANEKO Y; YAMAMOTO N; SEKIGAWA I
    THE PRODUCTION OF BETA-CHEMOKINES INDUCED BY HIV-2 ENVELOPE GLYCOPROTEIN
    AIDS
    
    L.P. Neoh et al., "THE PRODUCTION OF BETA-CHEMOKINES INDUCED BY HIV-2 ENVELOPE GLYCOPROTEIN", AIDS, 11(8), 1997, pp. 1062-1063
25. KANEKO H; NEOH LP; TAKEDA N; AKIMOTO H; HISHIKAWA T; HASHIMOTO H; HIROSE S; KARAKI S; TAKIGUCHI M; NAKAUCHI H; KANEKO Y; YAMAMOTO N; SEKIGAWA I
    HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 ENVELOPE GLYCOPROTEIN BINDS TO CD8 AS WELL AS TO CD4 MOLECULES ON HUMAN T-CELLS
    Journal of virology
    
    H. Kaneko et al., "HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 ENVELOPE GLYCOPROTEIN BINDS TO CD8 AS WELL AS TO CD4 MOLECULES ON HUMAN T-CELLS", Journal of virology, 71(11), 1997, pp. 8918-8922
26. KANEKO H; HISHIKAWA T; SEKIGAWA I; HASHIMOTO H; OKUMURA K; KANEKO Y
    ROLE OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN THE INDUCTION OF HIV-1 GP120-MEDIATED CD4(-CELL ANERGY() T)
    Clinical and experimental immunology
    
    H. Kaneko et al., "ROLE OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN THE INDUCTION OF HIV-1 GP120-MEDIATED CD4(-CELL ANERGY() T)", Clinical and experimental immunology, 109(1), 1997, pp. 41-46
27. KOSHINO K; TOKANO Y; HISHIKAWA T; SEKIGAWA I; TAKASAKI Y; HASHIMOTO H
    DETECTION OF ANTIBODIES TO HIV-1 GP41-DERIVED AND HLA CLASS-II ANTIGEN-DERIVED PEPTIDES IN SLE PATIENTS
    Scandinavian journal of rheumatology
    
    K. Koshino et al., "DETECTION OF ANTIBODIES TO HIV-1 GP41-DERIVED AND HLA CLASS-II ANTIGEN-DERIVED PEPTIDES IN SLE PATIENTS", Scandinavian journal of rheumatology, 24(5), 1995, pp. 288-292
28. SEKIGAWA I; KOSHINO K; HISHIKAWA T; KANEKO H; TAKASAKI Y; HASHIMOTO H; HIROSE S; INAGAKI Y; YAMAMOTO N
    INHIBITORY EFFECT OF THE IMMUNOSUPPRESSANT FK506 ON APOPTOTIC CELL-DEATH INDUCED BY HIV-1 GP120
    Journal of clinical immunology
    
    I. Sekigawa et al., "INHIBITORY EFFECT OF THE IMMUNOSUPPRESSANT FK506 ON APOPTOTIC CELL-DEATH INDUCED BY HIV-1 GP120", Journal of clinical immunology, 15(6), 1995, pp. 312-317
29. SEKIGAWA I; HISHIKAWA T; KANEKO H; HASHIMOTO H; HIROSE S; INGAKI Y; YAMAMOTO N
    FK506 CAN INHIBIT APOPTOTIC CELL-DEATH INDUCED BY THE HIV-1 ENVELOPE GLYCOPROTEIN GP120
    AIDS
    
    I. Sekigawa et al., "FK506 CAN INHIBIT APOPTOTIC CELL-DEATH INDUCED BY THE HIV-1 ENVELOPE GLYCOPROTEIN GP120", AIDS, 8(11), 1994, pp. 1623-1624
30. SEKIGAWA I; HISHIKAWA T; KANEKO H; HASHIMOTO H; HIROSE S; INGAKI Y; YAMAMOTO N
    FK506 CAN INHIBIT APOPTOTIC CELL-DEATH INDUCED BY THE HIV-1 ENVELOPE GLYCOPROTEIN GP120
    AIDS
    
    I. Sekigawa et al., "FK506 CAN INHIBIT APOPTOTIC CELL-DEATH INDUCED BY THE HIV-1 ENVELOPE GLYCOPROTEIN GP120", AIDS, 8(11), 1994, pp. 1623-1624